AstraZeneca PLC's Fiscal Year is From January To December - All Figures are in USD, Millions.
The item "Cash-Flows-Other-Operating" stands at -579.00 Million United States Dollars for the trailing twelve months (TTM) period ending 09/30/2024, the highest value since 12/31/2021.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 40.00 Million United States Dollars compared to the value the year prior.
The 1 year change is 40.00 Million United States Dollars.
The 3 year change is -302.00 Million United States Dollars.
The 5 year change is -360.00 Million United States Dollars.
The 10 year change is -423.00 Million United States Dollars.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Cash Flows Other Operating | 905,699,262,464.00 |
![]() | Johnson & Johnson - Cash Flows Other Operating | 486,508,953,600.00 |
![]() | AbbVie Inc - Cash Flows Other Operating | 399,570,305,024.00 |
![]() | Roche Holding AG - Cash Flows Other Operating | 317,433,206,677.55 |
![]() | Novartis AG - Cash Flows Other Operating | 255,096,620,580.91 |